Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

US Patent 11001578 · Granted May 11, 2021

Estimated economic value: $19,699,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Orchestrated intelligent supply chain optimizer2025
Orchestrated intelligent supply chain optimizer2024
Peptide docking vehicle for targeted nucleic acid delivery2024
Composition and methods of RNAi prophylactics and therapeutics for treatment of 2024
Hydraulic screw tensioner2024
Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({42023
Enzyme inhibitors2023
Enzyme inhibitors2023
Enzyme inhibitors2023
Enzyme inhibitors2023
Substituted imidazo[4,5-c]pyridine compounds and compositions thereof2022
Inhibitors of plasma kallikrein2022